
Due to the on-going health and economic situation across the globe, and the associated uncertainties regarding health and safety, transportation, catering, and access issues, MDPI is offering the possibility of organizing webinars, alongside our other conferences.
With the support of MDPI’s journal Cancers, a webinar on "Mechanism of Immunotherapy" will be held, moving from the high quality reports, recently published in Cancers Special Issue, entitled "Mechanism of Immunotherapy”. The webinar aims at allowing scientists, who participated to the collection and received a very high feedback, to present their latest research and discuss further issues with their peers.
The webinar will conclude with a Q&A session where speakers will be able to answer the attendees’ questions. The webinar will be recorded and uploaded to Sciforum.
I am looking forward to meeting you up.
Antonio Curti
Date: 11 April 2022
Time: 4:00pm CEST | 10:00am EDT | 10:00pm CST Asia
Webinar ID: 863 7313 6203
Webinar Secretariat: cancers.webinar@mdpi.com
IRCCS Azienda ospedaliero-universitaria di Bologna, Seràgnoli Hematology Unit, Italy;
Education and Training
1997 - MD degree at the University of Bologna, School of Medicine
1998-2000 - Fellow in Experimental and Clinical Hematology at the University of Bologna, School of Medicine
2002 - PhD in Clinical and Experimental Hematology
1998 - Visiting Investigator at the Department of Dermatology, Immunotherapy Unit, Erlangen (Germany)
2000-2002 Research Fellow at the Department of Experimental Oncology, Gene, Therapy and Immunotherapy Unit, Istituto Nazionale dei Tumori, Milan, Italy
2003 - Visiting Investigator at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University,Division of Immunology and Hematopoiesis, Baltimore (USA)
Research activity
• Acute myeloid leukemia and mylodysplastic syndromes
• Basic immunology focusing on tumor escape mechanisms in leukemia, involving leukemia microenvironment: the role of indoleamine 2,3- dioxygenase and tryptophan metabolism
• Adoptive immunotherapy with alloreactive NK cells in acute myeloid leukemia patients
Positions
From 2006 – Attending Physician at the Institute of Hematology “L.&A. Seràgnoli”, University of Bologna, Italy.
From 2013 - Group Leader Cell Therapy Unit at Bologna Institute of Hematology
From 2018 – Group Leader, Acute Leukemia and Mylodysplastic Syndromes
Program at Bologna Institute of Hematology
This webinar is part of the Cancers Topical Collection "Mechanism of Immunotherapy in Cancers". To find out more about this topical collection and to submit to it, please click here.